October 22, 2014
Interim report January-September 2014
Media
October 15, 2014
Orexo appoints Nomination Committee and publishes financial calendar 2014/2015
October 13, 2014
Nexstim launches its Initial Public Offering and will apply for dual listing on Nasdaq First North Finland and Nasdaq First North Sweden
October 13, 2014
Orexo submits application to FDA for expanded label of ZUBSOLV®
October 02, 2014
Nexstim Supports 6th International Symposium on Navigated Brain Stimulation in Neurosurgery
September 29, 2014
Aerocrine AB and Microsoft collaborate to test secure, cloud-based remote medical device monitoring.
September 24, 2014
TWELVE-MONTH FOLLOW-UP OF CERAMENT™ WITH GENTAMICIN CONFIRMS SIGNIFICANT AND SUSTAINED ERADICATION OF CHRONIC INFECTION AND DEMONSTRATED FORMATION OF NEW BONE
September 22, 2014
Tengion Retains Jefferies to Explore Strategic Options for the Company
September 19, 2014
Nexstim Plans an Initial Public Offering on NASDAQ OMX First North
September 18, 2014
Nexstim Launches Next Generation NBS 5 System